Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China · Delayed Price · Currency is CNY 15.07
-0.12 (-0.79%)
Sep 4, 2026, 3:00 PM CST
SHA:603456 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,579 | 1,543 | 2,749 | 3,206 | 1,095 | 1,121 |
Short-Term Investments | 1,318 | - | - | - | - | - |
Trading Asset Securities | - | - | - | - | - | 26.06 |
Cash & Short-Term Investments | 2,897 | 1,543 | 2,749 | 3,206 | 1,095 | 1,147 |
Cash Growth | 3.05% | -43.87% | -14.27% | 192.71% | -4.49% | 225.79% |
Accounts Receivable | 1,128 | 1,125 | 1,255 | 997.69 | 767.03 | 850.02 |
Other Receivables | 14.63 | 11.62 | 11.8 | 8.32 | 6.46 | 5.72 |
Receivables | 1,142 | 1,137 | 1,266 | 1,006 | 773.49 | 855.74 |
Inventory | 1,515 | 1,416 | 1,929 | 1,959 | 2,021 | 1,682 |
Other Current Assets | 68.38 | 1,442 | 127.5 | 142.55 | 102.87 | 87.38 |
Total Current Assets | 5,623 | 5,537 | 6,071 | 6,314 | 3,993 | 3,772 |
Property, Plant & Equipment | 4,289 | 4,338 | 4,274 | 3,722 | 3,144 | 2,645 |
Long-Term Investments | 212.85 | 199.65 | 108.08 | 121.88 | 109.13 | 101.07 |
Goodwill | 12.12 | 12.6 | 88.6 | 110.11 | 111.11 | 70.35 |
Other Intangible Assets | 481.19 | 464.9 | 516.11 | 504.74 | 454.03 | 412.47 |
Long-Term Deferred Tax Assets | 0.04 | 0.07 | 1.68 | 0.75 | 24.43 | 11.21 |
Long-Term Deferred Charges | 18.74 | 50.5 | 64.76 | 73.2 | 69.07 | 16.21 |
Other Long-Term Assets | 0.31 | 0.01 | 2.9 | 4.74 | 8.38 | 12.15 |
Total Assets | 10,637 | 10,603 | 11,127 | 10,852 | 7,914 | 7,040 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,102 | 1,068 | 1,459 | 1,198 | 1,245 | 988.14 |
Accrued Expenses | 169.1 | 232.34 | 202.63 | 227.81 | 201.85 | 168.05 |
Short-Term Debt | - | 50.43 | - | - | 50.05 | 498.84 |
Current Portion of Long-Term Debt | - | - | 201.93 | 7.77 | 200.21 | - |
Current Portion of Leases | 5.53 | 7.14 | 7.79 | 6.78 | 6.59 | 1.01 |
Current Income Taxes Payable | 53.7 | 61.1 | 55.74 | 55.3 | 78.8 | 75.37 |
Current Unearned Revenue | 74.13 | 111.63 | 69.75 | 75.41 | 83.08 | 49.64 |
Other Current Liabilities | 34.52 | 47.33 | 49.84 | 85.95 | 348.37 | 303.65 |
Total Current Liabilities | 1,439 | 1,578 | 2,046 | 1,657 | 2,214 | 2,085 |
Long-Term Debt | - | - | 194.25 | 389.05 | 83.99 | 201.49 |
Long-Term Leases | 5.59 | 6.05 | 8.03 | 11.89 | 10.6 | 3.25 |
Long-Term Unearned Revenue | 149.31 | 149.79 | 139.89 | 109.12 | 101.2 | 97.31 |
Long-Term Deferred Tax Liabilities | 78.2 | 74.29 | 87.47 | 101.47 | 106.26 | 76.55 |
Other Long-Term Liabilities | 4.58 | 4.64 | 41.76 | 50.77 | 25.76 | - |
Total Liabilities | 1,677 | 1,812 | 2,518 | 2,319 | 2,542 | 2,463 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 889.45 | 889.45 | 895.24 | 899.49 | 834.25 | 832.6 |
Additional Paid-In Capital | 4,285 | 4,285 | 4,380 | 4,499 | 2,058 | 1,985 |
Retained Earnings | 3,939 | 3,640 | 3,350 | 3,190 | 2,515 | 1,802 |
Treasury Stock | -212.67 | -102 | -99.9 | -132.01 | -113.12 | -44.43 |
Comprehensive Income & Other | -0.24 | 11.75 | 11.52 | 4.65 | 2.26 | 1.49 |
Total Common Equity | 8,901 | 8,724 | 8,537 | 8,461 | 5,297 | 4,577 |
Minority Interest | 59.78 | 66.48 | 72.91 | 71.94 | 75.1 | - |
Shareholders' Equity | 8,960 | 8,791 | 8,610 | 8,533 | 5,372 | 4,577 |
Total Liabilities & Equity | 10,637 | 10,603 | 11,127 | 10,852 | 7,914 | 7,040 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 11.12 | 63.62 | 412 | 415.49 | 351.44 | 704.58 |
Net Cash (Debt) | 2,886 | 1,479 | 2,337 | 2,791 | 743.98 | 442.29 |
Net Cash Growth | 20.47% | -36.69% | -16.27% | 275.13% | 68.21% | - |
Net Cash Per Share | 3.26 | 1.66 | 2.62 | 3.13 | 0.90 | 0.53 |
Filing Date Shares Outstanding | 873.09 | 891.14 | 889.45 | 899.49 | 834.25 | 832.6 |
Total Common Shares Outstanding | 873.09 | 891.14 | 889.45 | 899.49 | 834.25 | 832.6 |
Working Capital | 4,184 | 3,960 | 4,025 | 4,658 | 1,779 | 1,687 |
Book Value Per Share | 10.19 | 9.79 | 9.60 | 9.41 | 6.35 | 5.50 |
Tangible Book Value | 8,407 | 8,247 | 7,932 | 7,846 | 4,732 | 4,094 |
Tangible Book Value Per Share | 9.63 | 9.25 | 8.92 | 8.72 | 5.67 | 4.92 |
Buildings | 2,763 | 2,768 | 1,966 | 1,786 | 1,612 | 1,562 |
Machinery | 5,043 | 5,024 | 4,665 | 4,350 | 4,010 | 3,684 |
Construction In Progress | 858.81 | 757.46 | 1,566 | 1,198 | 839.25 | 471.51 |